Literature DB >> 11982303

Lyme arthritis.

Elena M Massarotti1.   

Abstract

Infection with B. burgdorferi can cause a large joint inflammatory arthritis in patients who have not been treated for early Lyme disease; the knee is the most common joint affected. The diagnosis depends on a history of known exposure to the spirochete, characteristic clinical features, and serologic studies (ELISA and Western blot) confirming exposure to the spirochete. In most patients, antibiotic therapy is curative, but in a smaller percentage of patients, the presence of the HLA-DR beta 1*0401 haplotype can trigger treatment-resistant arthritis, in which antibiotic therapy is ineffective; in these instances, remittive agents, such as hydroxychloroquine and methotrexate, are indicated. Arthroscopic synovectomy may be considered when antibiotic therapy is not curative. Fibromyalgia can follow infection with B. burgdorferi but is unresponsive to antibiotic therapy; it is treated with tricyclic antidepressants and an exercise program. Lyme arthritis is the only chronic inflammatory arthritis in which the specific cause is known and can be cured. As such, it serves as an excellent model with which to study the pathogenesis of more common inflammatory arthritides, such as rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982303     DOI: 10.1016/s0025-7125(03)00088-9

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  Seronegative Lyme arthritis.

Authors:  A Holl-Wieden; S Suerbaum; H J Girschick
Journal:  Rheumatol Int       Date:  2007-04-04       Impact factor: 2.631

Review 2.  The anti-borreliae efficacy of phytochemicals and micronutrients: an update.

Authors:  Anna Goc; Matthias Rath
Journal:  Ther Adv Infect Dis       Date:  2016-07-04

3.  Effects of a zoonotic pathogen, Borrelia burgdorferi, on the behavior of a key reservoir host.

Authors:  Richard S Ostfeld; Dustin Brisson; Kelly Oggenfuss; Jill Devine; Michael Z Levy; Felicia Keesing
Journal:  Ecol Evol       Date:  2018-03-26       Impact factor: 2.912

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.